Literature DB >> 11321240

Changes in the pathogenesis and prevention of chronic lung disease of prematurity.

E Bancalari1.   

Abstract

With the increasing survival of extremely premature infants there is a large number of them who are developing chronic lung disease (CLD), but the severity of the lung damage is considerably less than that observed in the classic form of bronchopulmonary dysplasia (BPD). Because many of these infants have only a mild initial respiratory distress and therefore do not receive aggressive ventilation, it is clear that factors other than oxygen toxicity and barotrauma are involved in the pathogenesis of this new milder type of CLD. CLD results from the interaction of multiple factors that can injure the immature lung. For this reason the prevention must be based on the elimination of all the factors implicated in its pathogenesis. Clinical and epidemiological data strongly suggest that infections, either prenatal or nosocomial, and the presence of a patent ductus arteriosus (PDA) play a major role in the development of CLD in these infants. For this reason, efforts to prevent CLD in extremely low birth weight infants should include an aggressive approach to the prevention and treatment of prenatal and neonatal infections and an early closure of the PDA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11321240     DOI: 10.1055/s-2001-12940

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  24 in total

1.  Fetal origins of neonatal lung disease: understanding the pathogenesis of bronchopulmonary dysplasia.

Authors:  Karen K Mestan; Robin H Steinhorn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-30       Impact factor: 5.464

2.  HFOV in premature neonates: effects on pulmonary mechanics and epithelial lining fluid cytokines. A randomized controlled trial.

Authors:  Giovanni Vento; Piero G Matassa; Franco Ameglio; Ettore Capoluongo; Enrico Zecca; Luca Tortorolo; Mara Martelli; Costantino Romagnoli
Journal:  Intensive Care Med       Date:  2005-02-17       Impact factor: 17.440

3.  Reactive Oxygen Species, Biomarkers of Microvascular Maturation and Alveolarization, and Antioxidants in Oxidative Lung Injury.

Authors:  Arwin M Valencia; Maria A Abrantes; Jamal Hasan; Jacob V Aranda; Kay D Beharry
Journal:  React Oxyg Species (Apex)       Date:  2018-11

Review 4.  Heme oxygenase in neonatal lung injury and repair.

Authors:  Phyllis A Dennery
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 5.  Role of innate host defenses in susceptibility to early-onset neonatal sepsis.

Authors:  James L Wynn; Ofer Levy
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

6.  Factor structure of coping: two studies of mothers with high levels of life stress.

Authors:  Sheri P Eisengart; Lynn T Singer; H Lester Kirchner; Meeyoung Oh Min; Sarah Fulton; Elizabeth J Short; Sonia Minnes
Journal:  Psychol Assess       Date:  2006-09

7.  Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.

Authors:  Carl T D'Angio; William M Maniscalco
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

8.  Transfer of the active form of transforming growth factor-beta 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia.

Authors:  Jack Gauldie; Tom Galt; Philippe Bonniaud; Clinton Robbins; Margaret Kelly; David Warburton
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

9.  Neutrophil and monocyte adhesion molecules in bronchopulmonary dysplasia, and effects of corticosteroids.

Authors:  P Ballabh; M Simm; J Kumari; A N Krauss; A Jain; C Califano; M L Lesser; S Cunningham-Rundles
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-01       Impact factor: 5.747

10.  Vocal fold paralysis following surgical ductal closure in extremely low birth weight infants: a case series of feeding and respiratory complications.

Authors:  W F Malcolm; C Hornik; A Evans; P B Smith; C M Cotten
Journal:  J Perinatol       Date:  2008-11       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.